Home
About
Overview
Sharing Data
ORCID
Help
History (15)
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
The integration of personalized medicine into health systems: progress and a path forward.
IKK signaling network: TNF cytotoxicity, computational modeling and regulation
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
Use of a Computerized Decisional Analysis Tool in Patients With Urgency Urinary Incontinence.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (63)
More Search Options
Match
Type
Why
Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis.
Academic Article
Why?
A Novel Epigenetic Mechanism in the Pathogenesis of Myelodysplastic Syndrome (MDS)
Academic Article
Why?
Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Academic Article
Why?
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Academic Article
Why?
Cheng, Jason X.
Person
Why?
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Academic Article
Why?
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS).
Academic Article
Why?
Comparison of de novo vs. therapy-related acute leukemia (AL) and myelodysplastic syndromes (MDS) in adults with balanced chromosome aberrations of 11q23.
Academic Article
Why?
Cytogenetic responses to a 5-day dosing schedule of decitabine in patients (Pts) with myelodysplastic syndromes (MDS).
Academic Article
Why?
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
Academic Article
Why?
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Academic Article
Why?
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Academic Article
Why?
Analysis of DNA Methylation and Histone H3 Trimethylation at Lysine 27 (H3K27me3) in Myelodysplastic Syndrome (MDS) with a Novel Sequential Methylated DNA Immunoprecipitation (SMeDIP) and Sequential Chromatin-Immunoprecipitation (SChIP) Technology: A Pilot Study of Refractory Cytopenia with Multilineage Dysplasia (RCMD)
Academic Article
Why?
Identifying distinct differentiation/lineage-specific, drug-sensitive chromatin structures and the underlying novel mutations in MDS and AML. Platform presentation. The 13th International Symposium on Myelodysplastic Syndromes
Academic Article
Why?
Lymphoblastic leukemia following MDS or MDS/MPN: clinical evidence for stem cell origins of these disorders.
Academic Article
Why?
Per Page
15
25
50
100
Page
of 5
Next
Prev
Search Criteria
Myelodysplastic syndromes
MDS
Filter by Type
All
(63)
People
(23)
Research
(40)
_
Click "Why?" to see why an item matched the search.